Published in JAMA on March 06, 1967
Use and control of cephalosporins. J Clin Pathol (1971) 5.12
Clinical studies of cefazolin and comparison with other cephalosporins. Antimicrob Agents Chemother (1973) 1.28
Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections. Yale J Biol Med (1968) 1.08
Cephacetrile: clinical evaluation in 27 patients. Antimicrob Agents Chemother (1973) 0.91
Immunohaematological cross-allergenicity between penicillin and cephalothin in humans. Clin Exp Immunol (1968) 0.88
Penicillin-induced haemolytic anaemia. Br Med J (1968) 0.75
Positive direct Coombs' test without hemolytic anemia, attributed to penicillin therapy. Can Med Assoc J (1968) 0.75
Acute intravascular haemolysis associated with cephalexin therapy. Postgrad Med J (1972) 0.75
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med (1976) 7.89
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science (1975) 5.13
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med (1982) 4.70
Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. Blood (1986) 3.00
Evidence for differences in erythrocyte surface receptors for the malarial parasites, Plasmodium falciparum and Plasmodium knowlesi. J Exp Med (1977) 2.92
Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion. J Clin Invest (1987) 2.91
THE ROLE OF "FOLIC ACID" AND BIOTIN IN THE UTILIZATION OF PANTOTHENIC ACID BY THE RAT. Science (1943) 2.85
Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol (1990) 2.39
Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J Exp Med (1988) 2.31
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol (1991) 2.23
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 2.22
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
Studies on the purification and characterization of human factor 8. J Clin Invest (1972) 1.97
The Duffy blood group determinants: their role in the susceptibility of human and animal erythrocytes to Plasmodium knowlesi malaria. Br J Haematol (1977) 1.90
Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood (1977) 1.69
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med (1975) 1.65
The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol (1981) 1.64
THE PRODUCTION OF FOLIC ACID BY RAT LIVER IN VITRO. Science (1943) 1.49
Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle. Am J Physiol (1996) 1.45
Column chromatography of nucleotides over thymidylate-cellulose. J Chromatogr (1966) 1.42
Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol (1973) 1.36
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am J Hematol (1977) 1.27
The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain. J Clin Invest (1991) 1.26
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. Blood (1981) 1.25
Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood (1994) 1.21
Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin. J Clin Invest (1977) 1.21
The Duffy blood group phenotype in American blacks infected with Plasmodium vivax in Vietnam. Am J Trop Med Hyg (1978) 1.21
Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin. Blood (1984) 1.21
Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets. Blood (1981) 1.20
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med (1988) 1.19
Studies on the role of red blood cell glycoproteins as receptors for invasion by Plasmodium falciparum merozoites. Mol Biochem Parasitol (1982) 1.18
Anti-i, a frequent cold agglutinin in infectious mononucleosis. Vox Sang (1966) 1.17
Identification of an erythrocyte component carrying the Duffy blood group Fya antigen. Science (1984) 1.16
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med (1975) 1.15
Von Willebrand's disease: combined qualitative and quantitative abnormalities. N Engl J Med (1977) 1.14
A model of fulminant hepatic failure in the rabbit. Gastroenterology (1978) 1.12
Bacterial degradation of biotin. Catabolism of 14C-biotin and its sulfoxides. J Biol Chem (1966) 1.12
A variant form of hypergranular promyelocytic leukaemia (M3) Br J Haematol (1980) 1.09
Characteristics of blast crisis in chronic granulocytic leukemia. Blood (1977) 1.09
Studies on the Factor VIII/von Willebrand factor antigen on human platelets. Thromb Res (1975) 1.08
In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease. Proc Natl Acad Sci U S A (1985) 1.08
Defibrination in acute pancreatitis. Ann Intern Med (1972) 1.08
Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood (1975) 1.06
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. J Clin Invest (1971) 1.06
A second example of anti-Lan. Vox Sang (1968) 1.03
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. J Clin Invest (1975) 1.03
Thrombocytopenia with sodium cephalothin therapy. Ann Intern Med (1972) 1.02
Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease. N Engl J Med (1983) 1.02
Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med (1984) 1.02
Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol (1988) 1.01
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants. Science (1976) 1.01
Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med (1991) 1.00
Immunological studies of factor VIII in haemophilia and von Willebrand's disease. Nat New Biol (1973) 1.00
Altered processing of integrin receptors during keratinocyte activation. Exp Cell Res (1991) 1.00
Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity. Am J Med (1967) 0.98
Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion (1986) 0.98
Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. Blood (1972) 0.98
Rh-incompatible platelet transfusions--risks and consequences of sensitizing immunosuppressed patients. N Engl J Med (1971) 0.97
Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med (1969) 0.97
Bacterial and enzymatic degradation of biotin. Biochem Biophys Res Commun (1965) 0.97
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity. J Clin Invest (1978) 0.96
Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol (1983) 0.96
Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis. Hum Pathol (1974) 0.95
Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c. Ann Intern Med (1978) 0.95
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood (1981) 0.94
Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand's disease. Blood (1982) 0.94
Direct evidence for the conversion of dethiobiotin to biotin in Aspergillus niger. J Biol Chem (1966) 0.94
An erythrocyte Pr auto-antibody with sialoglycoprotein specificity in a patient with purine nucleoside phosphorylase deficiency. Transfusion (1985) 0.93
Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule. N Engl J Med (1978) 0.93
Molecular biology of factor VIII/von Willebrand Factor. Thromb Haemost (1978) 0.92
Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med (1977) 0.92
Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A. Thromb Res (1975) 0.92
Selective binding of the factor VIII/von Willebrand factor protein to human platelets. Blood (1980) 0.92
Warfarin anticoagulation: difficulties in interpretation of the prothrombin time. Thromb Res (1982) 0.92
Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor. Blood (1986) 0.92
von Willebrand factor binds specifically to sulfated glycolipids. J Biol Chem (1986) 0.91
Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease. Arthritis Rheum (1974) 0.91
The Chediak-Higashi syndrome: continuous suspension cultures derived from peripheral blood. Blood (1969) 0.91
Hemolytic anemia associated with cephalothin. JAMA (1971) 0.91
Conformational regulation of the fibronectin binding and alpha 3beta 1 integrin-mediated adhesive activities of thrombospondin-1. J Biol Chem (2001) 0.91
Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease. Blood (1986) 0.90
Conversion of dethiobiotin to biotin in Aspergillus niger. J Biol Chem (1968) 0.89
Dominant inheritance of hemophilia A in three generations of women. Blood (1975) 0.89
Evidence for function of a metal ion in the activity of dihydroorotase from Zymobacterium oroticum. J Biol Chem (1965) 0.89
Studies of the human factor VIII/von Willebrand's factor protein. II. Identification and characterization of the von Willebrand protein. Blood (1975) 0.88
Acute promyelocytic leukaemia: haemorrhagic manifestation and morphologic criteria. Br J Haematol (1975) 0.88
Purification and characterization of human platelet von Willebrand factor. Br J Haematol (1994) 0.88
Myelofibrosis in chronic granulocytic leukemia. Blood (1971) 0.88
Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes. Virology (1993) 0.88
Thrombosis with epsilon aminocaproic acid therapy. Am J Clin Pathol (1971) 0.87
Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. J Biol Chem (1986) 0.86
Changes in erythrocyte I agglutinogen and anti-I-agglutinins during Mycoplasma pneumoniae infection in man. J Immunol (1967) 0.86
Identification of the thrombin receptor on human platelets by chemical crosslinking. J Clin Invest (1986) 0.86
Structure of Mn2+ and Cu2+ complexes with L-methionine, S-methyl-L-cysteine, L-threonine and L-serine. Biochim Biophys Acta (1969) 0.86
Congenital dysfibrinogenemias. Ann Intern Med (1972) 0.86
Immunological studies of factor VIII (antihaemophiliac globulin) in haemophilia A. Nat New Biol (1971) 0.86